JAC Advance Access originally published online on November 6, 2007
Journal of Antimicrobial Chemotherapy 2008 61(1):26-38; doi:10.1093/jac/dkm416
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Systematic review |
Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis
Department of Infectious Diseases, Catholic University, Rome, Italy
Received 23 July 2007; returned 4 October 2007; revised 23 August 2007; accepted 8 October 2007
* Corresponding author. Tel: +39-06-30155527; Fax: +39-06-3054519; E-mail: etacconelli{at}rm.unicatt.it
Background: Current evidence does not provide a clear definition of the association between methicillin-resistant Staphylococcus aureus (MRSA) isolation and previous antibiotic use. A systematic review was performed to determine whether antibiotic exposure is a risk factor for the isolation of MRSA.
Methods: MEDLINE and EMBASE databases were searched to identify studies published between 1976 and 2007 on the role of antibiotics as a risk factor for MRSA isolation in adult patients. The outcome of interest was MRSA isolation. Summary statistics were risk ratios (RR) comparing MRSA-positive patients to those without S. aureus isolation or with methicillin-susceptible S. aureus isolation.
Results: Seventy-six studies, including a total of 24 230 patients, met the inclusion criteria. Antibiotic exposure was determined in the 126 ± 184 (mean ± SD) days preceding MRSA isolation. The risk of acquiring MRSA was increased by 1.8-fold [95% confidence interval (CI), 1.7–1.9; P < 0.001] in patients who had taken antibiotics. The RR for single classes of antibiotics was 3 (95% CI, 2.5–3.5) for quinolones, 2.9 (95% CI, 2.4–3.5) for glycopeptides, 2.2 (95% CI, 1.7–2.9) for cephalosporins and 1.9 (95% CI, 1.7–2.2) for other β-lactams. Significant heterogeneity was detected among studies. A regression analysis revealed that the heterogeneity was linked to the length of time in which antibiotic exposure was detected before MRSA isolation (more or less than 180 days).
Conclusions: This meta-analysis shows a clear association between exposure to antibiotics and MRSA isolation. This information may be useful for researchers in designing future studies and for policy decision-making on the appropriate management of antibiotic therapies.
Keywords: antibiotic resistance , Gram-positive , antimicrobials
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. I. A. Rijnders, R. H. Deurenberg, M. L. L. Boumans, J. A. A. Hoogkamp-Korstanje, P. S. Beisser, E. E. Stobberingh, and on behalf of the Antibiotic Resistance Surveillanc Flucloxacillin, still the empirical choice for putative Staphylococcus aureus infections in intensive care units in the Netherlands J. Antimicrob. Chemother., November 1, 2009; 64(5): 1029 - 1034. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W S Lim, S V Baudouin, R C George, A T Hill, C Jamieson, I Le Jeune, J T Macfarlane, R C Read, H J Roberts, M L Levy, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009 Thorax, October 1, 2009; 64(Suppl_3): iii1 - iii55. [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Elliott, T. E. Zaoutis, A. B. Troxel, A. Loh, and R. Keren Empiric Antimicrobial Therapy for Pediatric Skin and Soft-Tissue Infections in the Era of Methicillin-Resistant Staphylococcus aureus Pediatrics, June 1, 2009; 123(6): e959 - e966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Ellis, M. E. Griffith, J. H. Jorgensen, D. R. Hospenthal, K. Mende, and J. E. Patterson Presence and Molecular Epidemiology of Virulence Factors in Methicillin-Resistant Staphylococcus aureus Strains Colonizing and Infecting Soldiers J. Clin. Microbiol., April 1, 2009; 47(4): 940 - 945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. FURLOW Preventing Drug-resistant Infections in Health Care Radiol. Technol., January 1, 2009; 80(3): 217 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Pakyz, C. MacDougall, M. Oinonen, and R. E. Polk Trends in Antibacterial Use in US Academic Health Centers: 2002 to 2006 Arch Intern Med, November 10, 2008; 168(20): 2254 - 2260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Tacconelli, M. A. Cataldo, G. De Pascale, D. Manno, T. Spanu, A. Cambieri, M. Antonelli, M. Sanguinetti, G. Fadda, and R. Cauda Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex J. Antimicrob. Chemother., November 1, 2008; 62(5): 1130 - 1137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Seaton Daptomycin: rationale and role in the management of skin and soft tissue infections J. Antimicrob. Chemother., November 1, 2008; 62(suppl_3): iii15 - iii23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Aldeyab, D. L. Monnet, J. M. Lopez-Lozano, C. M. Hughes, M. G. Scott, M. P. Kearney, F. A. Magee, and J. C. McElnay Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis J. Antimicrob. Chemother., September 1, 2008; 62(3): 593 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Vernaz, H. Sax, D. Pittet, P. Bonnabry, J. Schrenzel, and S. Harbarth Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile J. Antimicrob. Chemother., September 1, 2008; 62(3): 601 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Harbarth and M. H. Samore Interventions to control MRSA: high time for time-series analysis? J. Antimicrob. Chemother., September 1, 2008; 62(3): 431 - 433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Moellering Jr Intrafamilial Spread of Methicillin-Resistant Staphylococcus aureus Infections--Reply JAMA, June 4, 2008; 299(21): 2511 - 2512. [Full Text] [PDF]
|
|